Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders (EVA-DLAI)

Access to housing, in the current context of extreme tension in the rental housing market in Paris and throughout the Ile-de-France region, is proving to be extremely complex for people with mental health problems.National and international scientific studies have quantified the problem of homelessness and precarious or inappropriate housing among patients suffering from psychiatric disorders, and show the impact of housing problems on the consumption of psychiatric care.The DÉLAI's mission is to facilitate access to housing for people enrolled in a psychiatric care pathway, with teams from the psychiatric sectors

Study Overview

• Status: Recruiting
• Conditions: Mental Disorder
• Intervention / Treatment: Other: patients with mental disorders

Detailed Description

• Written and oral information provided to the patient by the patient's referring psychiatrist (Investigator of one of the five recruiting sites) during a regular consultation appointment.
• Initial assessment (V inclusion): reminder of the information concerning the research, collection of consent, collection of sociodemographic data, and standardized assessment scales (quality of life, clinical state, level of functioning) + standardized semi-structured interview for the diagnosis of psychiatric disorders + completion by the referring psychiatrist of the data corresponding to the patient's care pathway.
• Then follow-up visit at an annual rate (V1 ... VX), and DLAI exit assessment (V exit) as soon as the patient stops benefiting from the DLAI.

• Study Type: Interventional
• Enrollment (Estimated): 50
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Alexandra PHAM-scottez, Pr; Phone Number: + 33 (0)1 45 65 83 70 / 81 08; Email: a.pham@ghu-paris.fr

Study Locations

• France
  • Paris, France, 75014
    • Recruiting
    • Centre Hospitalier Sainte Anne
    • Contact: Alexandra PHAM - SCOTTEZ, MD; Phone Number: +33 145 65 89 18; Email: a.pham@ch-sainte-anne.fr
    • Principal Investigator: Alexandra PHAM - SCOTTEZ, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

patient followed for a psychiatric disorder patient benefiting from a DLAI

Exclusion Criteria:

patient not followed for psychiatric disorder patient who refused to participate in the research

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: patients with mental disorders; administration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research	Other: patients with mental disorders; administration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
improvement of quality of life	World Health Organization Quality of Life-26,26-item self-assessment questionnaire for assessing quality of life covering four major dimensions: physical health, mental health, social relationships and environment	one year
improvement of quality of life	quality of life rating scale (each item is rated from 0 to 6, giving a total score out of 42 points), assessing interpersonal relationships (relationships with close acquaintances and social initiatives), social status, intrapsychic functioning (degree of motivation, anhedonia and capacity for empathy) and regular activities.	one year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
clinical condition	Mini International Neuropsychiatric Interview : structured diagnostic interview, relatively short in duration, exploring in a standardized way the main psychiatric disorders	one year

Collaborators and Investigators

• Sponsor: Centre Hospitalier St Anne

Study record dates

Study Major Dates

• Study Start (Actual): July 27, 2020
• Primary Completion (Estimated): July 27, 2030
• Study Completion (Estimated): December 27, 2030

Study Registration Dates

• First Submitted: September 27, 2024
• First Submitted That Met QC Criteria: October 9, 2024
• First Posted (Actual): October 10, 2024

Study Record Updates

• Last Update Posted (Actual): October 10, 2024
• Last Update Submitted That Met QC Criteria: October 9, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Schizophrenia Spectrum and Other Psychotic Disorders; Psychotic Disorders; Mental Disorders
• Other Study ID Numbers: D20-P007

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No